These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7596120)

  • 21. Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter.
    Howard PA
    Ann Pharmacother; 1999 Jan; 33(1):38-47. PubMed ID: 9972384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.
    Ellenbogen KA; Stambler BS; Wood MA; Sager PT; Wesley RC; Meissner MC; Zoble RG; Wakefield LK; Perry KT; Vanderlugt JT
    J Am Coll Cardiol; 1996 Jul; 28(1):130-6. PubMed ID: 8752805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of transient atrial rhythm occurring between typical atrial flutter and its termination with class III drugs.
    Morita N; Kobayashi Y; Iwasaki YK; Hayashi M; Miyauchi Y; Atarashi H; Tanaka K; Katoh T; Mizuno K
    Pacing Clin Electrophysiol; 2008 Aug; 31(8):943-54. PubMed ID: 18684249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
    J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion of atrial flutter by ibutilide is associated with increased atrial cycle length variability.
    Guo GB; Ellenbogen KA; Wood MA; Stambler BS
    J Am Coll Cardiol; 1996 Apr; 27(5):1083-9. PubMed ID: 8609325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of ibutilide for termination of atrial fibrillation and flutter.
    Ellenbogen KA; Clemo HF; Stambler BS; Wood MA; VanderLugt JT
    Am J Cardiol; 1996 Oct; 78(8A):42-5. PubMed ID: 8903275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group.
    Nørgaard BL; Wachtell K; Christensen PD; Madsen B; Johansen JB; Christiansen EH; Graff O; Simonsen EH
    Am Heart J; 1999 Jun; 137(6):1062-9. PubMed ID: 10347332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of azimilide dihydrochloride on circus movement atrial flutter in the canine sterile pericarditis model.
    Restivo M; Hegazy M; Caref EB; Avitable MJ; Assadi MA; el-Hamami M; Yin H; Piracha M; Brooks RR; el-Sherif N
    J Cardiovasc Electrophysiol; 1996 Jul; 7(7):612-24. PubMed ID: 8807407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ibutilide for cardioversion of atrial flutter: efficacy of a single dose in recent-onset arrhythmias.
    Andò G; Di Rosa S; Rizzo F; Carerj S; Bramanti O; Giannetto M; Arrigo F
    Minerva Cardioangiol; 2004 Feb; 52(1):37-42. PubMed ID: 14765036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vanoxerine, a new drug for terminating atrial fibrillation and flutter.
    Matsumoto N; Khrestian CM; Ryu K; Lacerda AE; Brown AM; Waldo AL
    J Cardiovasc Electrophysiol; 2010 Mar; 21(3):311-9. PubMed ID: 19817929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter.
    Mountantonakis SE; Moutzouris DA; Tiu RV; Papaioannou GN; McPherson CA
    Am J Emerg Med; 2006 Jul; 24(4):407-12. PubMed ID: 16787796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electropharmacologic effects of class I and class III antiarrhythmia drugs on typical atrial flutter: insights into the mechanism of termination.
    Tai CT; Chen SA; Feng AN; Yu WC; Chen YJ; Chang MS
    Circulation; 1998 May; 97(19):1935-45. PubMed ID: 9609087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of nifekalant for acute conversion of atrial flutter: the possible termination mechanism of typical atrial flutter.
    Morita N; Tanaka K; Yodogawa K; Hayashi M; Akutsu K; Yamamoto T; Satoh N; Kobayashi Y; Katoh T; Takano T
    Pacing Clin Electrophysiol; 2007 Oct; 30(10):1242-53. PubMed ID: 17897127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of azimilide and dofetilide in the dog right atrial enlargement model of atrial flutter.
    Restivo M; Hegazy M; El-Hamami M; Yin H; Caref EB; Assadi MA; Brooks RR; El-Sherif N
    J Cardiovasc Electrophysiol; 2001 Sep; 12(9):1018-24. PubMed ID: 11573691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.
    Feld GK; Venkatesh N; Singh BN
    Circulation; 1986 Jul; 74(1):197-204. PubMed ID: 3708774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Azd7009: a new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model.
    Goldstein RN; Khrestian C; Carlsson L; Waldo AL
    J Cardiovasc Electrophysiol; 2004 Dec; 15(12):1444-50. PubMed ID: 15610294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization and surgical ablation of atrial flutter after the classic Fontan repair.
    Gandhi SK; Bromberg BI; Schuessler RB; Turken BJ; Boineau JP; Cox JL; Huddleston CB
    Ann Thorac Surg; 1996 Jun; 61(6):1666-78; discussion 1678-9. PubMed ID: 8651766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of ibutilide vs. transoesophageal atrial pacing for the termination of type I atrial flutter.
    Mazza A; Fera MS; Bisceglia I; Bettiol F; Pulignano G; Tanzi P; Gaudio C; Giovannini E
    Europace; 2004 Jul; 6(4):301-6. PubMed ID: 15172654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of acute inducible atrial flutter in dogs by using an ibutilide-polymer-coated pacing electrode.
    Labhasetwar V; Strickberger SA; Underwood T; Davis J; Levy RJ
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):449-55. PubMed ID: 9514191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophysiologic effects of SD-3212, a new class I antiarrhythmic drug, on canine atrial flutter and atrial action-potential characteristics.
    Fujiki A; Tani M; Hayashi H; Mizumaki K; Inoue H; Uemura H; Nakaya H
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):471-5. PubMed ID: 9156356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.